Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-28T00:30:07.175Z Has data issue: false hasContentIssue false

Role of Coinfecting Strains in Recurrent Clostridium difficile Infection

Published online by Cambridge University Press:  30 August 2016

Janet Sun
Affiliation:
Infection Control, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Tracy Mc Millen
Affiliation:
Infection Control, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
N. Esther Babady
Affiliation:
Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Mini Kamboj*
Affiliation:
Infection Control, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Department of Medicine, Weill Cornell Medical College, New York, New York
*
Address correspondence to Mini Kamboj, 1275 York Avenue, New York, NY 10065 ([email protected]).

Abstract

The contribution of mixed infection in recurrent Clostridium difficile infection (CDI) episodes is not known. Among paired isolates from 52 patients, mixed infection due to >1 toxigenic strain of C. difficile was identified in 8% of first episodes. Among recurrences, relapse from 1 or both co-infecting strains was uncommon; it was detected in a single case each.

Infect Control Hosp Epidemiol 2016;1481–1484

Type
Concise Communications
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Lessa, FC, Mu, Y, Bamberg, WM, et al. Burden of Clostridium difficile infection in the United States. New Engl J Med 2015;372:825834.Google Scholar
2. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431455.Google Scholar
3. Kamboj, M, Khosa, P, Kaltsas, A, Babady, NE, Son, C, Sepkowitz, KA. Relapse versus reinfection: surveillance of Clostridium difficile infection. Clin Infect Dis 2011;53:10031006.Google Scholar
4. Behroozian, AA, Chludzinski, JP, Lo, ES, et al. Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping. Infect Control Hosp Epidemiol 2013;34:961966.Google Scholar
5. van den Berg, RJ, Ameen, HA, Furusawa, T, Claas, EC, van der Vorm, ER, Kuijper, EJ. Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies. J Med Microbiol 2005;54:173179.Google Scholar
6. Griffiths, D, Fawley, W, Kachrimanidou, M, et al. Multilocus sequence typing of Clostridium difficile . J Clin Microbiol 2010;48:770778.CrossRefGoogle ScholarPubMed
7. O’Neill, GL, Beaman, MH, Riley, TV. Relapse versus reinfection with Clostridium difficile . Epidemiol Infect 1991;107(3):627635.CrossRefGoogle ScholarPubMed
8. Eyre, DW, Walker, AS, Griffiths, D, et al. Clostridium difficile mixed infection and reinfection. J Clin Microbiol 2012;50:142144.Google Scholar
9. Eyre, DW, Cule, ML, Griffiths, D, Crook, DW, Peto, TE, Walker, AS, et al. Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission. PLoS Computat Biol 2013;9:e1003059.Google Scholar